JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120432

Tertiapin Q, blocker of inward-rectifier r K+ channels

Be the first to review this product! Submit a review

|

(8 Publications)

MW 2295.8 Da, Purity >95%. Achieve your results faster with highly validated, pure and trusted compounds.
2 Images
Chemical Structure - Tertiapin Q, blocker of inward-rectifier r K+ channels (AB120432)
  • Chemical Structure

Lab

Chemical Structure - Tertiapin Q, blocker of inward-rectifier r K+ channels (AB120432)

2D chemical structure image of ab120432, Tertiapin Q, blocker of inward-rectifier r K+ channels

Cellular Activation - Tertiapin Q, blocker of inward-rectifier r K+ channels (AB120432)
  • CellAct

Unknown

Cellular Activation - Tertiapin Q, blocker of inward-rectifier r K+ channels (AB120432)

Tertiapin Q, blocker of inward-rectifier r K+ channels

Image from Montalbano A, et al. Plos One, 10(10), e0140369. Fig 3,; doi: 10.1371/journal.pone.0140369

Key facts

CAS number

252198-49-5

Purity

>95%

Form

Solid

form

Molecular weight

2295.8 Da

Molecular formula

C<sub>1</sub><sub>0</sub><sub>0</sub>H<sub>1</sub><sub>6</sub><sub>3</sub>N<sub>3</sub><sub>1</sub>O<sub>2</sub><sub>3</sub>S<sub>4</sub>

PubChem

92131436

Nature

Synthetic

Solubility

Soluble in water

Biochemical name

tertiapin-Q

Canonical smiles

CCC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC3CSSCC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC3=O)CC4=CNC5=CC=CC=C54)CCCCN)CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)C(=O)NC(C(=O)N1)CC(=O)N)CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C)N)CCC(=

Isomeric smiles

CC[C@H](C)[C@H]1C(=O)NC(C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]3CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CC4=CNC5=CC=CC=C54)CCCCN)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N)C(=O)N[C@H](C(=O)N1)CC(=O)N)CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)CCC(=O)N)CC6=CNC=N6)[C@@H](C)CC)[C@@H](C)CC

InChi

InChI=1S/C100H163N31O23S4/c1-10-52(6)79-98(152)129-80(53(7)11-2)99(153)130-81(54(8)12-3)100(154)131-37-23-30-74(131)97(151)123-67(40-57-44-110-50-113-57)91(145)118-64(31-32-75(106)132)88(142)125-71-47-157-158-48-72(126-89(143)65(38-51(4)5)119-83(137)55(9)105)95(149)121-68(41-76(107)133)92(146)127-73(96(150)122-69(42-77(108)134)93(147)128-79)49-156-155-46-70(84(138)112-45-78(135)114-61(27-16-20-34-102)85(139)115-60(82(109)136)26-15-19-33-101)124-87(141)63(29-18-22-36-104)116-86(140)62(28-17-21-35-103)117-90(144)66(120-94(71)148)39-56-43-111-59-25-14-13-24-58(56)59/h13-14,24-25,43-44,50-55,60-74,79-81,111H,10-12,15-23,26-42,45-49,101-105H2,1-9H3,(H2,106,132)(H2,107,133)(H2,108,134)(H2,109,136)(H,110,113)(H,112,138)(H,114,135)(H,115,139)(H,116,140)(H,117,144)(H,118,145)(H,119,137)(H,120,148)(H,121,149)(H,122,150)(H,123,151)(H,124,141)(H,125,142)(H,126,143)(H,127,146)(H,128,147)(H,129,152)(H,130,153)/t52-,53-,54-,55-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,79-,80?,81-/m0/s1

InChiKey

GYOKDEHVCCTTJF-VJPNZKQTSA-N

IUPAC Name

(1R,4S,7S,10S,16S,22S,25S,28R,33R,36S,39S,42S,49R,52S)-36,39-bis(4-aminobutyl)-N-[2-[[(2S)-6-amino-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]-25,52-bis(2-amino-2-oxoethyl)-4-(3-amino-3-oxopropyl)-49-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-methylpentanoyl]amino]-16,19,22-tris[(2S)-butan-2-yl]-7-(1H-imidazol-4-ylmethyl)-42-(1H-indol-3-ylmethyl)-3,6,9,15,18,21,24,27,35,38,41,44,50,53-tetradecaoxo-30,31,46,47-tetrathia-2,5,8,14,17,20,23,26,34,37,40,43,51,54-tetradecazatricyclo[26.16.10.010,14]tetrapentacontane-33-carboxamide

Product details

Sold under license granted by the University of Pennsylvania.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

The Journal of neuroscience : the official journal of the Society for Neuroscience 41:7086-7102 PubMed34261700

2021

G-Protein-Gated Inwardly Rectifying Potassium (Kir3/GIRK) Channels Govern Synaptic Plasticity That Supports Hippocampal-Dependent Cognitive Functions in Male Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Souhail Djebari,Guillermo Iborra-Lázaro,Sara Temprano-Carazo,Irene Sánchez-Rodríguez,Mauricio O Nava-Mesa,Alejandro Múnera,Agnès Gruart,José M Delgado-García,Lydia Jiménez-Díaz,Juan D Navarro-López

Biomedicine & pharmacotherapy = Biomedecine & phar 101:362-370 PubMed29499411

2018

GIRK1-mediated inwardly rectifying potassium current suppresses the epileptiform burst activities and the potential antiepileptic effect of ML297.

Applications

Unspecified application

Species

Unspecified reactive species

Yian Huang,Yuwen Zhang,Shuzhen Kong,Kai Zang,Shize Jiang,Li Wan,Lulan Chen,Guoxiang Wang,Min Jiang,Xin Wang,Jie Hu,Yun Wang

Nature communications 8:1862 PubMed29192252

2017

Restoration of patterned vision with an engineered photoactivatable G protein-coupled receptor.

Applications

Unspecified application

Species

Unspecified reactive species

Michael H Berry,Amy Holt,Joshua Levitz,Johannes Broichhagen,Benjamin M Gaub,Meike Visel,Cherise Stanley,Krishan Aghi,Yang Joon Kim,Kevin Cao,Richard H Kramer,Dirk Trauner,John Flannery,Ehud Y Isacoff

Frontiers in pharmacology 7:45 PubMed27014060

2016

Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.

Applications

Unspecified application

Species

Unspecified reactive species

Bruno Bragança,Nádia Oliveira-Monteiro,Fátima Ferreirinha,Pedro A Lima,Miguel Faria,Ana P Fontes-Sousa,Paulo Correia-de-Sá

PloS one 10:e0140369 PubMed26460748

2015

Pharmacological Characterization of 5-HT1A Autoreceptor-Coupled GIRK Channels in Rat Dorsal Raphe 5-HT Neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Alberto Montalbano,Renato Corradetti,Boris Mlinar

Hypertension (Dallas, Tex. : 1979) 63:783-9 PubMed24420545

2014

Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.

Applications

Unspecified application

Species

Unspecified reactive species

Meena Murthy,Shengxin Xu,Gianmichele Massimo,Martin Wolley,Richard D Gordon,Michael Stowasser,Kevin M O'Shaughnessy

The Journal of neuroscience : the official journal of the Society for Neuroscience 33:18951-65 PubMed24285900

2013

Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptor.

Applications

Unspecified application

Species

Unspecified reactive species

Bruno Vilar,Jérôme Busserolles,Bing Ling,Sophie Laffray,Lauriane Ulmann,Fanny Malhaire,Eric Chapuy,Youssef Aissouni,Monique Etienne,Emmanuel Bourinet,Francine Acher,Jean-Philippe Pin,Alain Eschalier,Cyril Goudet

Journal of hypertension 30:1827-33 PubMed22743686

2012

Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.

Applications

Unspecified application

Species

Unspecified reactive species

Meena Murthy,Elena A B Azizan,Morris J Brown,Kevin M O'Shaughnessy
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com